Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5375198 | 6322567 | F | 5375198-1 | 20070510 | 20070621 | 20070629 | EXP | JP-ASTRAZENECA-2007AP02814 | AZPRODUW00 | 24618 | DY | F | Y | 58 | KG | 20070629 | MD | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5375198 | 1008648562 | PS | FASLODEX | 1 | INTRAMUSCULAR | PERIOD 1 | 021344 | ||||
| 5375198 | 1008648563 | SS | FASLODEX | 1 | INTRAMUSCULAR | PERIOD 2 | 021344 | ||||
| 5375198 | 1008648564 | SS | FASLODEX | 1 | INTRAMUSCULAR | PERIOD 3 | 021344 | ||||
| 5375198 | 1008648565 | C | INNOLET N | 2 | SUBCUTANEOUS | ||||||
| 5375198 | 1008648566 | C | NORVASC | 1 | ORAL | ||||||
| 5375198 | 1008648567 | C | DIOVAN | 1 | ORAL | ||||||
| 5375198 | 1008648568 | C | INNOLET R | 2 | SUBCUTANEOUS |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5375198 | 1008648562 | BREAST CANCER |
| 5375198 | 1008648565 | DIABETES MELLITUS |
| 5375198 | 1008648566 | HYPERTENSION |
| 5375198 | 1008648567 | HYPERTENSION |
| 5375198 | 1008648568 | DIABETES MELLITUS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5375198 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5375198 | OPTIC NEURITIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5375198 | 1008648562 | 20070427 | 20070427 | 1 | DAY |